山东大学耳鼻喉眼学报 ›› 2018, Vol. 32 ›› Issue (6): 30-37.doi: 10.6040/j.issn.1673-3770.0.2018.021

• 论著 • 上一篇    下一篇

MicroRNA-24对人喉鳞癌细胞生物学行为的影响

许莉1,王志颐1,陈伟1,薛飞1,张勇1,程友1,季俊峰1,崔鹏程2,江满杰1   

  1. 1.中国人民解放军东部战区总医院耳鼻咽喉科, 江苏 南京 210002;
    2.空军军医大学唐都医院耳鼻咽喉头颈外科, 陕西 西安 710038
  • 发布日期:2018-11-29
  • 通讯作者: 江满杰. E-mail:jiangmjdoc@163.com
  • 作者简介:许莉. E-mail:xulinjzy@126.com
  • 基金资助:
    江苏省青年医学重点人才项目(QNRC2016917)

Effect of MicroRNA-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells

XU Li1, WANG Zhiyi1, CHEN Wei1, XUE Fei1, ZHANG Yong1, CHENG You1, JI Junfeng1, CUI Pengcheng2, JIANG Manjie1   

  1. Department of Otolaryngology Head and Neck Surgery, Tangdu Hospital, Air Force Military Medical University, Xian 710038, Shaanxi, China
  • Published:2018-11-29

摘要: 目的 探讨MicroRNA-24(miR-24)对喉鳞状细胞癌(LSCC)Hep-2、AMC-HN-8细胞增殖、侵袭及凋亡等生物学行为的影响。 方法 应用LipofectamineTM 2000转染上调Hep-2、AMC-HN-8细胞中miR-24的表达,通过荧光定量PCR验证转染效率;然后分别采用MTT法、克隆形成实验、细胞划痕实验、Transwell侵袭实验流式细胞分析技术分析外源上调miR-24后Hep-2、AMC-HN-8细胞增殖、迁移、侵袭及凋亡的影响。 结果 miR-24质粒稳定转染Hep-2、AMC-HN-8细胞后miR-24表达明显上调。与转染miR-NC组和空白对照组相比,转染miR-24能明显降低Hep-2细胞的增殖、迁移和侵袭能力;同时,转染miR-24能明显增加Hep-2、AMC-HN-8细胞的凋亡能力。 结论 miR-24异常表达与LSCC Hep-2、AMC-HN-8细胞的生物学行为密切相关,可能发挥抑癌作用。

关键词: 喉鳞癌, MicroRNA-24, 增殖, 迁移, 侵袭, 凋亡

Abstract: Objective The effect of miR-24 on the proliferation, migration, invasion, and apoptosis of LSCC cells was examined. Methods After constructing Hep-2 and AMC-HN-8 cells to overexpress miR-24 by cell transfection, the proliferation of Hep-2 and AMC-HN-8 cells was detected by MTT assay and a cloning assay. A scratch test and Transwell assay were conducted to detect cell migration and invasion abilities, and the effect on apoptosis was analyzed by using flow cytometry analysis. Results After cell transfection, qRT-PCR confirmed upregulation of miR-24 in Hep-2/miR-24 and AMC-HN-8/miR-24 cells. MTT and colony formation assays showed that upregulation of miR-24 significantly reduced the proliferation of LSCC cells. Additionally, the capacity for colony formation in Hep-2/miR-24 and AMC-HN-8/miR-24 cells was significantly reduced compared to that of control cells. The scratch test and Transwell assay showed that the migration and invasion ability of miR-24 were significantly reduced. Flow cytometry showed that overexpression of miR-24 significantly enhanced apoptosis in LSCC cells. These results suggest that miR-24 inhibits the proliferation, invasion, and metastasis and increases the apoptosis of LSCC cells. Conclusion Abnormal expression of miR-24 is closely related to properties of LSCC cells. miR-24 inhibits the proliferation and migration and enhances the apoptosis of LSCC cells.

Key words: Laryngeal squamous carcinoma, MicroRNA-24, Inhibition, Proliferation, Invasion, Apoptosis

中图分类号: 

  • R739.65
[1] Genden EM, Ferlito A, Silver CE, et al. Evolution of the management of laryngeal cancer[J]. Oral Oncol, 2007, 43(5):431-439.
[2] Yu YH, Kuo HK, Chang KW. The evolving transcriptome of head and neck squamous cell carcinoma: a systematic review[J]. PLoS One, 2008, 3(9):e3215.
[3] Li L, Zhang ZM, Liu Y, et al. DNA microarrays-based microRNA expression profiles derived from formalin-fixed paraffin-embedded tissue blocks of squammous cell carcinoma of larynx[J]. Zhonghua Bing Li Xue Za Zhi, 2010, 39(6):391-395.
[4] Wery M, Kwapisz M, Morillon A. Noncoding RNAs in gene regulation[J]. Wiley Interdiscip Rev Syst Biol Med, 2011, 3(6):728-738.
[5] Le HB, Zhu WY, Chen DD, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients[J]. Med Oncol, 2012, 29(5):3190-3197.
[6] Chen L, Luo L, Chen W, et al. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53[J]. Biomed Pharmacother, 2016, 84:1113-1118.
[7] Zhao J, Hu C, Chi J, et al. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7[J]. Oncol Rep, 2016, 36(2):1143-1149.
[8] Nguyen T, Rich A, Dahl R. MiR-24 promotes the survival of hematopoietic cells[J]. PLoS One, 2013, 8(1):e55406.
[9] Liu Z, Liu Z, Zhang Y, et al. miR-24 represses metastasis of human osteosarcoma cells by targeting Ack1 via AKT/MMPs pathway[J]. Biochem Biophys Res Commun, 2017, 486(2):211-217.
[10] Yu G, Jia Z, Dou Z. miR-24-3p regulates bladder cancer cell proliferation, migration, invasion and autophagy by targeting DEDD[J]. Oncol Rep, 2017, 37(2):1123-1131.
[11] Gong JP, Yang L, Tang JW, et al. Overexpression of microRNA-24 increases the sensitivity to paclitaxel in drug-resistant breast carcinoma cell lines via targeting ABCB9[J]. Oncol Lett, 2016, 12(5):3905-3911.
[12] Liu R, Zhang H, Wang X, et al. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma[J]. Oncotarget, 2015, 6(41):43831-43842.
[13] Organista-Nava J, Gomez-Gomez Y, Illades-Aguiar B, et al. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia[J]. Oncol Rep, 2015, 33(4):1639-1649.
[14] Li YQ, Lu JH, Bao XM, et al. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1[J]. J Exp Clin Cancer Res, 2015, 34:130.
[15] Kang M, Xiao J, Wang J, et al. MiR-24 enhances radiosensitivity in nasopharyngeal carcinoma by targeting SP1[J]. Cancer Med, 2016, 5(6):1163-1173.
[16] Lynch SM, Mckenna MM, Walsh CP, et al. miR-24 regulates CDKN1B/p27 expression in prostate cancer[J]. Prostate, 2016, 76(7):637-648.
[17] Ma Y, She XG, Ming YZ, et al. miR-24 promotes the proliferation and invasion of HCC cells by targeting SOX7[J]. Tumour Biol, 2014, 35(11):10731-10736.
[18] Lin SC, Liu CJ, Lin JA, et al. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis[J]. Oral Oncol, 2010, 46(3):204-208.
[1] 王奎荣,饶丽华,李专,段丙志. 幽门螺旋杆菌感染在喉鳞癌发生发展中的作用及机制[J]. 山东大学耳鼻喉眼学报, 2018, 32(6): 38-42.
[2] 苏杰,艾昕,马春梅,杨馥宇,黄帅. 急性高眼压大鼠外侧膝状体神经元细胞自噬与凋亡的关系[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 68-71.
[3] 李国彬,张占成,王新颜. 上调miR-200b对人喉癌Hep-2细胞增殖、迁移和侵袭能力的影响[J]. 山东大学耳鼻喉眼学报, 2018, 32(4): 53-57.
[4] 赵小燕,吴彩琴,任晓勇,王正辉. 白花蛇舌草多糖提取物诱导Hep-2细胞凋亡与抑制侵袭机制[J]. 山东大学耳鼻喉眼学报, 2018, 32(2): 84-87.
[5] 张彩霞,刘阳云,江文,刘庚勋,曹杭,陈琼,张纪帅. 一氧化氮对鼻咽癌CNE-2细胞株化疗增敏效应的研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 72-78.
[6] 周毅波,龚小蓉,于锋. MiR-150调控Nanog对鼻咽癌侧群细胞增殖、侵袭的影响[J]. 山东大学耳鼻喉眼学报, 2017, 31(5): 79-84.
[7] 李军,李晓明,吴彦桥,邸斌,苗玉花,王嘉. 累及鼻颅底区域鼻腔鼻窦骨源性良性肿瘤的鼻内镜手术治疗[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 31-36.
[8] 周华群,张立庆,徐朝琪,姜盼,王愿,刘晓静,董伟达. 姜黄素联合白藜芦醇抑制人头颈部肿瘤细胞系增殖的机制研究[J]. 山东大学耳鼻喉眼学报, 2017, 31(2): 67-72.
[9] 许元腾,陈瑞庆,林功标,方秀玲,俞舒娟,梁晓华,张榕. RNAi沉默PDCD4基因对人喉癌Hep-2细胞增殖及β-catenin表达的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(5): 110-114.
[10] 李钦,陈彦林,马焱燚,张永东. γ干扰素对变应性鼻炎大鼠鼻腔灌洗液中嗜酸粒细胞凋亡及Eotaxin水平的影响[J]. 山东大学耳鼻喉眼学报, 2016, 30(4): 30-33.
[11] 周小彦,林鹏,孙士铭,张雅娜,李晓劼,石玉凯. 鼻窦炎患者血清HMGB1表达及其临床意义[J]. 山东大学耳鼻喉眼学报, 2016, 30(2): 56-58.
[12] 陈春丽, 宋宗明, 贾新国, 周仲楼, 汪朝阳. 促红细胞生成素抑制氧化损伤诱导的人眼Müller细胞凋亡[J]. 山东大学耳鼻喉眼学报, 2015, 29(3): 65-71.
[13] 李安, 李娜, 姜彦, 于龙刚, 刘慧, 许彤, 孔祥斌. 鼻内镜手术治疗鼻-眶-颅底骨纤维异常增殖症4例[J]. 山东大学耳鼻喉眼学报, 2015, 29(2): 36-40.
[14] 刘海洋, 李甦雁, 张正培, 范巍. 改良膜分割与双手膜清除技术在23G玻璃体手术治疗增殖性糖尿病视网膜病变中的对比[J]. 山东大学耳鼻喉眼学报, 2015, 29(1): 52-55.
[15] 邱志利, 蒋晓平. 误吞异物迁移至颈部伴感染1例[J]. 山东大学耳鼻喉眼学报, 2014, 28(4): 105-106.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!